PTEN expression and methylation status in oral squamous cell carcinoma

Oncology Reports

Volumn 19, Issue 6, 2008, Pages 1429-1434

  Kurasawa, Yoshinori ^a   Shiiba, Masashi ^a   Nakamura, Megumi ^a   Fushimi, Kazuaki ^a   Ishigami, Takashi ^a   Bukawa, Hiroki ^b   Yokoe, Hidetaka ^b   Uzawa, Katsuhiro ^a   Tanzawa, Hideki ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Methylation; Oral squamous cell carcinoma; PTEN

Indexed keywords

MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; DNA; PTEN PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; CELL CULTURE; DNA METHYLATION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MOUTH TUMOR; MUTATION; PATHOLOGY; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 48849100558     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Li J, Yen C, Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
2. Steck PA, Pershouse MA, Jasser SA, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
3. Li DM and Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57: 2124-2129, 1997.
4. Tamura M, Gu J, Tran H and Yamada KM: PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 91: 1820-1828, 1999.
5. Hlobilkova A, Guldberg P, Thullberg M, Zeuthen J, Lukas J and Bartek J: Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Exp Cell Res 256: 571-577, 2000.
6. Myers MP, Pass I, Batty IH, et al: The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95: 13513-13518, 1998.
7. Di Cristofano A and Pandolfi PP: The multiple roles of PTEN in tumor suppression. Cell 100: 387-390, 2000.
8. Furnari FB, Huang HJ and Cavenee WK: The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58: 5002-5008, 1998.
9. Rasheed BK, Stenzel TT, McLendon RE, et al: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4197-4190, 1997.
10. Yokomizo A, Tindall DJ, Drabkin H, et al: PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene 17: 475-479, 1998.
11. Sato N, Tsunoda H, Nishida M, et al: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60: 7052-7056, 2000.
12. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663, 1997.
13. Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW and Barrett JC: Loss of KAI1 expression in the progression of colorectal cancer. Cancer Res 59: 5724-5731, 1999.
14. Uzawa K, Suzuki H, Tanzawa H, and Sato K: Mutational state of p16/CDKN2 and VHL genes in squamous cell carcinoma of the oral cavity. Int J Oncol 7: 895-899, 1995.
15. Creusot F, Acs G and Christman JK: Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2′-deoxycytidine. J Biol Chem 257: 2041-2048, 1982.
16. Timmermann S, Hinds PW and Munger K: Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state. Oncogene 17: 3445-3453, 1998.
17. Squarize CH, Castilho RM and Santos Pinto D Jr: Immuno-histochemical evidence of MTN in oral squarnous cell carcinoma and its correlation with the histological malignancy grading system. J Oral Pathol Med 31: 379-384, 2002.
18. Shin KH, Kim JM, Rho KS, Park KH, Oh JE and Min BM: Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas. Int J Oncol 21: 997-1001, 2002.
19. Chen Q, Samaranayake LP, Zhou H and Xiao L: Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncol 36: 95-99, 2000.
20. Lee JI, Soria JC, Hassan KA, et al: Loss of PTEN expression as a prognostic marker for tongue cancer. Arch Otolaryngol Head Neck Surg 127: 1441-1445, 2001.
21. Mavros A, Hahn M, Wieland I, et al: Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med 31: 270-276, 2002.
22. Snaddon J, Parkinson EK, Craft JA, Bartholomew C and Fulton R: Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer 84: 1630-1634, 2001.
23. Cheung TH, Lo KW, Yim SF, et al: Epigenetic and genetic alternation of PTEN in cervical neoplasm. Gynecol Oncol 93: 621-627, 2004.
24. Murao K, Kubo Y, Ohtani N, Hara E and Arase S: Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/ p16 and p53 pathways. Br J Dermatol 155: 999-1005, 2006.
25. Ma X, Ziel-van der Made AC, Autar B, et al: Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res 65: 5730-5739, 2005.
26. Tamura M, Gu J, Danen EH, Takino T, Miyamoto S and Yamada KM: PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidy-linositol 3-kinase/Akt cell survival pathway. J Biol Chem 274: 20693-20703, 1999.
27. Di Cristofano A, Pesce B, Cordon-Cardo C and Pandolfi PP: Pten is essential for embryonic development and tumour suppression. Nat Genet 19: 348-355, 1998.
28. Podsypanina K, Ellenson LH, Nemes A, et al: Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96: 1563-1568, 1999.
29. Stambolic V, Tsao MS, Macpherson D, Suzuki A, Chapman WB and Mak TW: High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res 60: 3605-3611, 2000.
30. Suzuki A, de la Pompa JL, Stambolic V, et al: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8: 1169-1178, 1998.